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After internalization, ubiquitinated signaling receptors are delivered to early endosomes. There, they are sorted and
incorporated into the intralumenal invaginations of nascent multivesicular bodies, which function as transport
intermediates to late endosomes. Receptor sorting is achieved by Hrs—an adaptor-like protein that binds membrane
PtdIns3P via a FYVE motif—and then by ESCRT complexes, which presumably also mediate the invagination process.
Eventually, intralumenal vesicles are delivered to lysosomes, leading to the notion that EGF receptor sorting into
multivesicular bodies mediates lysosomal targeting. Here, we report that Hrs is essential for lysosomal targeting but
dispensable for multivesicular body biogenesis and transport to late endosomes. By contrast, we find that the
PtdIns3P-binding protein SNX3 is required for multivesicular body formation, but not for EGF receptor degradation.
PtdIns3P thus controls the complementary functions of Hrs and SNX3 in sorting and multivesicular body biogenesis.
Citation: Pons V, Luyet P-P, Morel E, Abrami L, van der Goot FG, et al. (2008) Hrs and SNX3 functions in sorting and membrane invagination within multivesicular bodies. PLoS
Biol 6(9): e214. doi:10.1371/journal.pbio.0060214
Introduction
Cell surface lipids and proteins as well as solutes are
endocytosed into animal cells through several routes, includ-
ing clathrin-coated pits and vesicles, caveolae, and pathways
that do not depend on caveolae or clathrin [1,2]. Some
receptors may be differentially sorted into clathrin-coated
pits or caveolae/rafts, depending on their fate: signaling or
degradation [3–5]. These endocytic routes all seem to lead to
early endosomes eventually; from which some components,
including housekeeping receptors, are returned to the cell
surface for reutilization while others are transported to the
trans-Golgi network and the biosynthetic pathway. By
contrast, signaling receptors that need to be down-regulated,
including the activated EGF receptor, as well as other
endocytosed proteins and lipids, are efﬁciently sorted away
from recycling molecules within early endosomes, and are
then routed towards late endosomes and lysosomes, where
degradation occurs [6,7].
Major progress has been made in understanding the
molecular mechanisms responsible for EGF receptor sorting
in early endosomes. Sorting signals are provided by the
addition of multiple ubiquitin molecules to the receptor
cytoplasmic domain [8]. Ubiquitin coupled to the receptor
then binds Hrs through its ubiquitin interacting motif, while
Hrs also interacts simultaneously with membrane PtdIns3P
via a FYVE domain and with clathrin, leading to the
concentration of activated receptor molecules into speci-
alized clathrin-coated regions of early endosomes [9–11]. The
epidermal growth factor (EGF) receptor then interacts
sequentially with the ESCRT-I, ESCRT-II, and ESCRT-III
protein complexes, and eventually appears within lumenal
vesicles present in multivesicular regions of the early endo-
somes [12–14]—a process that uncouples activated receptors
from cytosolic signaling partners and thus efﬁciently termi-
nates signaling. This mechanism also appears to contribute to
the ubiquitin-independent sorting of the delta opioid G-
protein–coupled receptor in mammalian cells [15] and Sna3p
in yeast [16–18]. However, sorting of the melanosomal
protein Pmel17 does not depend on ubiquitin, Hrs, and
ESCRT components [19], and likewise, other proteins,
including proteins of the limiting membrane, are presumably
transported in an ESCRT-independent manner.
Eventually, these multivesicular regions detach—or ma-
ture—from early endosomes, and become free multivesicular
endosomes or bodies (MVBs), which then serve as transport
intermediates (ECVs or endosomal carrier vesicles), in the
microtubule-dependent transport towards late endosomes—
herein referred as ECV/MVBs. Formation of ECV/MVBs
appears to be itself under the control of EGF signaling [20]
and depends on annexin family members [21,22], whereas
conversion of the small GTPase Rab5 to Rab7 may occur on
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PLoS BIOLOGYearly endosome [23] or during early-to-late endosome trans-
port [24]. Upon fusion with late endosomes, ECV/MVB
lumenal vesicles are delivered to late endosomes, and are
eventually packaged within lysosomes, where they are
degraded together with their cargo of down-regulated
receptors.
Evidence shows that the sorting process mediated by Hrs
and ESCRTs is coupled somehow to the mechanism of
membrane invagination towards the lumen of the endosome,
including during the topologically equivalent process of HIV
budding at the plasma membrane, which takes advantage of
the ESCRT machinery [25–28]. In yeast, mutation of the genes
that encode ESCRTs and other components of this pathway
leads to the formation of an aberrant endosomal compart-
ment (Class E VPS phenotype). Then, endocytosed membrane
proteins that would normally be degraded accumulate in this
Class E compartment but also on the membrane of the
vacuole (see [12] and reference therein), which is functionally
equivalent to lysosomes. Similarly, Hrs knockout in Drosophila
[29] or knockdown in mammalian cells [20,30] causes a
reduction in the number of lumenal vesicles, presumably
because the downstream machinery responsible for mem-
brane invagination fails to assemble in cells lacking Hrs.
Knockdown of Tsg101, an ESCRT-I subunit, causes pleio-
tropic changes in early endosome morphology, including
tubulation, reduction in the number of lumenal vesicles [20],
and perhaps, the formation of a mammalian equivalent of the
yeast Class E compartment [31]. While it is clear that Hrs and
ESCRTs play an essential role in the lysosomal targeting of
many ubiquitinated proteins, the mechanism controlling
membrane invagination itself remains elusive. All proteins
that are known to induce membrane deformation act in the
topologically opposite direction—towards the cytoplasm—via
direct insertion into the bilayer or protein–lipid interactions
[32].
Here, we have further investigated the mechanisms that
control endosomal membrane dynamics, and in particular
the role of PtdIns3P and its effectors. Indeed, PtdIns3P is well
known to regulate endocytic membrane trafﬁc and protein
sorting through numerous effectors that contain FYVE or PX
PtdIns3P-binding domains. Moreover, PtdIns3P controls both
the sorting of signaling receptors [33] and the biogenesis of
lumenal membranes [34–36] at least in part via the FYVE-
containing protein Hrs [37]. Searching for other PtdIns3P
effectors, we screened proteins of the sorting nexin (SNX)
family that all contain the phosphoinositide-binding PX
domain [38]. Several SNX proteins play a role in protein
trafﬁcking and some contain a BAR domain, involved in
sensing and/or inducing membrane curvature [39]. We ﬁnd
that SNX3 plays a direct role in multivesicular body
formation, but is not involved in EGF receptor degradation.
By contrast, Hrs seems to be essential for lysosomal targeting
but dispensable for multivesicular body biogenesis and
transport to late endosomes.
Results
When ectopically expressed, green ﬂuorescent protein
(GFP)-tagged SNX3 showed a characteristic punctate distri-
bution, and colocalized with EEA1, an effector of the small
GTPase Rab5, and to some extent with the transferrin
receptor, but not with late endocytic markers, including
lysobisphosphatidic acid (LBPA) (Figure S1A) or Lamp1
(Figure 1C and 1F). Consistently, GFP-SNX3 cofractionated
with Rab5, but not with LBPA (Figure S1B). GFP-SNX3 was
thus primarily present on early endosomes, much like the
endogenous protein [40], and this association depended on
PtdIns3P and required an intact PtdIns3P-binding domain
PX (Figure S1C), as expected [40].
To investigate the possible role of SNX3, we ﬁrst tested
whether overexpression affected transport along the endo-
cytic pathway. SNX3 overexpression had no effect on EGF
receptor endocytosis, since internalized EGF colocalized with
both GFP-SNX3 and EEA1 in early endosomes within 10 min
of incubation at 37 8C (Figure S2A), much like in control cells
(unpublished data, see [33]). However, upon longer incuba-
tion times at 37 8C, EGF receptor degradation was delayed by
SNX3 overexpression (Figure 1A; quantiﬁcation in Figure
1B), in agreement with previous ﬁndings [40]. This delay was
caused by defective transport, since the bulk of endocytosed
EGF failed to reach late endosomes containing Lamp1
(Figures 1C and S3A) or LBPA (unpublished data) after 50
min in cells overexpressing SNX3. Then, EGF remained in
early endosomes containing GFP-SNX3 and EEA1 (Figures 1D
and S3B; quantiﬁcation in Figure 1E), whereas it was mostly
transported beyond early endosomes in control cells (Figure
S4A). The inhibitory effect of SNX3 was speciﬁc, since
overexpression of other SNX family members, including
SNX1, SNX2, and SNX16, did not interfere with EGF receptor
transport (Figure S5), as expected [41,42].
Much like with EGF receptor, endocytosis of the bulk phase
marker rhodamine-dextran was not affected by SNX3 over-
expression, and the tracer accumulated in early endosomes
containing GFP-SNX3 and EEA1 within 10 min at 37 8C
(Figure S2B). However, after a subsequent 40-min chase at 37
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The cell’s genetic program is modulated by extracellular signals that
activate cell surface receptors and, in turn, intracellular effectors, to
regulate transcription. For cells to function normally, these signals
must be turned off to avoid permanent activation—a situation often
associated with cancer. For many receptors, signaling is repressed,
or down-regulated, in a process that first internalizes and then
degrades the receptors. After receptors are removed from the cell
surface into structures called early endosomes, they are selectively
incorporated within vesicles that form inside the endosome. During
this process, endosomal membranes are pulled away from the
cytoplasm towards the endosome lumen, against the flow of
intracellular membrane traffic, eventually resulting in the formation
of a ‘‘multivesicular body’’ (vesicles within vesicles). The common
view is that these intralumenal vesicles are then delivered to
lysosomes, where they are degraded along with their receptor
cargo. We have investigated the mechanisms responsible for the
biogenesis of intralumenal vesicles in multivesicular bodies. We find
that the small protein SNX3, which binds the signaling lipid
phosphatidyl inositol-3-phosphate, is necessary for the formation
of intralumenal vesicles, but is not involved in the degradation of
the cell surface receptor for EGF. Conversely, we find that Hrs, which
also binds phosphatidyl inositol-3-phosphate and mediates receptor
sorting into intralumenal vesicles, is essential for lysosomal targeting
but dispensable for multivesicular body biogenesis. Phosphatidyl
inositol-3-phosphate thus controls the complementary functions of
Hrs and SNX3 in the sorting of signaling receptors and multivesicular
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Sorting and Membrane Deformation8C, SNX3 overexpression markedly impaired dextran trans-
port to late endosomes. The bulk of the tracer then remained
in early endosomes and failed to reach Lamp1-positive late
endocytic compartments (Figures 1F and S3C), as was
observed with the EGF receptor (Figure 1C and S3A) and in
contrast to control cells (Figure S4B). These inhibitory effects
of excess SNX3 were speciﬁc, since SNX3 overexpression did
not affect the transport of endocytosed Shiga toxin B-subunit
from early endosome (Figure S2C) to the trans-Golgi network
(Figures 1G and S3D; compare with controls in Figure S4C),
which requires SNX1 [43]. Altogether these observations
indicate that SNX3 overexpression caused the selective
retention of signaling receptors and bulk tracers in early
endosomes containing Rab5 and its effector EEA1, and
thereby inhibited more-distal steps of early-to-late endosome
transport.
To further investigate the role of SNX3 in early-to-late
endosome transport, we made use of vesicular stomatitis virus
(VSV), which infects cells from the endocytic pathway.
Indeed, endocytosed virions must be transported beyond
early endosomes for efﬁcient infection to occur [44,45].
Overexpression of SNX3 had no effect on endocytosis of VSV
(Figure 2A), as observed with EGF and dextran (Figure S2A
and S2B), but signiﬁcantly reduced VSV infection, which was
monitored by the synthesis of the viral glycoprotein G (Figure
2B). This inhibition did not result from some indirect effects
of SNX3 on the G-protein biosynthetic pathway, since
replication of the viral genome, quantiﬁed by real time-PCR
(RT-PCR), was also similarly reduced (Figure 2C), indicating
that excess SNX3 prevented efﬁcient release of the viral
nucleocapsid into the cytosol.
The viral nucleocapsid is released into the cytoplasm after
low pH-triggered fusion of the viral envelope with endosomal
membranes. To monitor viral fusion events, VSV was labeled
with self-quenching amounts of Dil, a ﬂuorescent long-chain
dialkylcarbocyanine dye, and bound to the cell surface at 4 8C
[44]. After endocytosis at 37 8C, the fusion of individual
virions was revealed in the light microscope by the
appearance of ﬂuorescent spots in endosomes, due to Dil
dequenching [44]. Strikingly, overexpression of SNX3 mark-
edly reduced VSV fusion (Figure 2D). Since VSV fusion
normally occurs beyond early endosomes [44,45], these
observations indicate that virions, much like EGF receptor
and dextran (Figure 1) remained trapped in early endosomes
in cells overexpressing SNX3.
The effects of SNX3 overexpression on the transport of
viral particles, EGF receptor, and ﬂuid phase markers led us
to investigate by electron microscopy whether endosome
morphology was then affected. SNX3 overexpression caused a
dramatic accumulation of multivesicular structures without
causing a general expansion of endosome vesicular regions
(Figure S6; quantiﬁcation in Figure 2E), perhaps suggesting
that only specialized regions of the early endosome are
competent to become MVBs. Multivesicular elements after
SNX3 overexpression were frequently clustered in groups of
ﬁve to ten individuals, as revealed in low (Figure S6) and high
(Figure 2F) magniﬁcation views, perhaps connected to each
other (Figure 2F). Immunogold labeling of cryosections
showed that GFP-SNX3 itself was abundant on the limiting
membrane of these multivesicular structures. These SNX3-
positive structures all exhibited a similar multivesicular and
spherical appearance (diameter ’ 0.4 lm), which closely
resembles the morphology of MVBs or ECVs that mediate
early-to-late endosome transport [46]—herein referred to as
ECV/MVBs. However, in marked contrast to free ECV/MVBs
during transport towards late endosomes, these SNX3-
positive structures exhibited the characteristic features of
early endosomes, including all early endosomal markers that
were tested (Figure 1 and see Figure 3). Moreover, the
transferrin receptor, which is restricted to early and recycling
endosomes, was found closely associated with these SNX3-
positive ECV/MVB-like structures (arrowheads in Figure 2H
and 2I), consistent with data from us (Figure 1) and others
[40]. The transferrin receptor was often present in tubulo-
cisternal elements connected to multivesicular elements
(Figure 2I), presumably corresponding to forming recycling
endosomes. It thus appears that SNX3 overexpression causes
the accumulation of multivesicular regions on early endo-
somal membranes. These ECV/MVB-like structures fail to
detach, or to mature, from early endosomes. Such a frustrated
process of ECV/MVB formation accounts nicely for our
observations that the transport of EGF receptor, VSV and
bulk markers beyond early endosomes is then inhibited (see
model, Figure S10).
In our electron microscopy analysis, SNX3 was often
observed on, or close to, membrane regions containing
electron-dense materials on the cytoplasmic membrane face
(e.g., Figure 2G), which resembled the early endosomal Hrs-
clathrin coat that mediates ubiquitinated receptor sorting
into lumenal vesicles during ECV/MVB formation on early
endosomes [9,10]. To further characterize SNX3 distribution,
we thus used the constitutively active mutant Rab5
Q79L, which
induces the formation of enlarged early endosomes by
promoting their homotypic fusion. On these large endo-
Figure 1. SNX3 in Endosomal Transport
(A and B) HeLa cells expressing GFP-SNX3 were incubated with 0.25 lg/ml EGF and 10 lg/ml cycloheximide for the indicated time periods. Cell lysates
(100 lg) were analyzed by SDS gel electrophoresis and western blotting with antibodies against EGFR (20-ESO4 against a peptide of the cytoplasmic
domain), a-tubulin (a-tub), or GFP. Blots were scanned and the quantification is shown in (B).
(C and D) After cell surface binding, biotin-EGF coupled to streptavidin-R-phycoerythrin was internalized for 50 min at 37 8C in HeLa cells expressing
GFP-SNX3. Cells were labeled with antibodies against Lamp1 (C) or EEA1 (D) and analyzed by triple channel fluorescence. The various combinations of
merged colors for (C) and (D) are shown in Figure S3A and S3B, respectively. Insets in the lower right are a magnification of the regions shown in the
boxes.
(E) Individual endosomes containing both EGF and EEA1 were counted in (D) and in control cells (Figure S4A). Values are expressed as a percentage of
the total number of EGF-containing endosomes (.10 cells per experiment).
(F) Rhodamine-dextran was pulsed for 10 min at 37 8C in HeLa cells expressing GFP-SNX3 and then chased for 40 min. Cells were analyzed as in (C and
D) using antibodies against Lamp1, and the various combinations of merged colors are in Figure S3C.
(G) After cell surface binding, Shiga toxin B-subunit conjugated to Cy3 was internalized for 50 min at 37 8C into HeLa cells expressing GFP-SNX3. Cells
were analyzed as in (C and D) using antibodies against Rab6, and the various combinations of merged colors are the same as in Figure S3D.
In (B and E), each condition is the mean of three independent experiments; standard errors are indicated.
(C, D, F, and G) Scale bar indicates 10 lm.
doi:10.1371/journal.pbio.0060214.g001
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receptors could be resolved by light microscopy from those
containing EEA1, indicating that components of the machi-
nery that sorts down-regulated receptors into ECV/MVB
internal vesicles are concentrated in speciﬁc early endosomal
domains [9]. When GFP-Rab5
Q79L was coexpressed with
monomeric red ﬂuorescent protein (mRFP)-SNX3, both
proteins were present on enlarged early endosomes, as
Figure 2. SNX3 in VSV Infection and MVB Biogenesis
(A) VSV (1 multiplicity of infection [MOI]) was bound on ice to the surface of control HeLa cells (ctrl) or HeLa cells expressing GFP-SNX3. Cells were
incubated for 15 min at 37 8C to allow VSV internalization. Then, total endosomes were prepared by fractionation and viral RNA was quantified by RT-
PCR. Values are expressed as a percentage of untransfected controls.
(B) Experiments were as in (A), except that cells were incubated for 3 h, instead of 15 min, at 37 8C to allow VSV infection to proceed. Cells were analyzed
by immunofluorescence with antibodies against VSV-G protein (left panels); stars indicate cells expressing GFP-SNX3 and not VSV-G. The total number
of cells expressing the G-protein was counted and is expressed as a percentage of the controls (’60% of untransfected control cells were infected).
(C) Experiments were as in (B), except that 0.1 MOI VSV was used and viral RNA replication was quantified by RT-PCR. Values are expressed as a
percentage of untransfected controls.
(D) Experiments were as in (A), except that 3 MOI Dil-labeled VSV was used and that cells were incubated for 35 min at 37 8C. Then, viral fusion events
were visualized as fluorescent spots (due to Dil dequenching) by fluorescence microscopy, and quantified. Values are expressed as in (B).
(E) Control HeLa cells (Figure S6A) or cells expressing GFP-SNX3 (Figure S6B) were fixed and embedded in Epon. Random fields of the different areas in
one section were captured at 25.0003 magnification (the procedure was repeated 33 for controls and 53 after GFP-SNX3 overexpression). Early
endosomes (EE) were identified as vacuole of 200–500 nm containing five or fewer clearly defined internal vesicles, and multivesicular regions as
vacuole of 200–500 nm containing five or more clearly defined spherical internal vesicles [66]. The volume of EE and multivesicular regions was
calculated by stereological means, and the mean values are expressed as a percentage of the cytoplasm volume 6 standard error of the mean (SEM).
(F–I) HeLa cells expressing GFP-SNX3 were analyzed by electron microscopy after immunogold labeling of cryosections using antibodies against GFP
([F–H], arrows) and the transferrin receptor (TfR) ([H and I], arrowheads) followed by proteinA-gold, as indicated.
In (A–E), each condition is the mean of at least three independent experiments; standard errors are indicated.
(B) Scale bar indicates 10 lm; (F–I) scale bar indicates 0.2 lm.
doi:10.1371/journal.pbio.0060214.g002
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Sorting and Membrane Deformationexpected. Approximately 90% of endosomes containing
SNX3 were also labeled with Rab5
Q79L, but some variation
in SNX3 association with individual Rab5
Q79L-endosomes was
observed (Figure 3), presumably reﬂecting different angles of
visualization in the confocal planes. SNX3 was clearly seen to
colocalize preferentially with Hrs (Figure 3A), ubiquitinated
proteins (Figure 3B), and clathrin (Figure 3C) in regions that
seemed devoid of EEA1 (Figure 3D). These observations
further demonstrate that ectopically expressed SNX3 accu-
mulates on early endosomal membranes. They also indicate
that this accumulation occurs preferentially in multivesicular
regions that contain, in addition to SNX3 itself, the protein
machinery responsible for sorting into lumenal vesicles. It
thus seems that the lumenal invagination process continues
in the presence of excess SNX3, leading to the accumulation
of multivesicular regions on early endosomes, but that more
distal transport events, including ECV/MVB detachment—or
maturation—(Figures 1A–1F and 2B–2D), are inhibited,
perhaps because excess SNX3 limits the access or binding
of downstream machineries.
Since overexpression of SNX3 caused an expansion of
multivesicular regions on early endosomes, we investigated
the impact of SNX3 down-expression on the formation of
lumenal vesicles by electron microscopy. To this end, the
lumen of ECV/MVBs was labeled with endocytosed horse-
radish peroxidase (HRP) pulsed for 15 min and then chased
for 30 min at 37 8C, after microtubule depolymerization with
10 lM nocodazole [46]. As expected [46], multivesicular
structures with the characteristic ECV/MVB morphology were
found in controls (Figure 4A, upper panel), accounting for
approximately 70% of the total HRP-positive structures (see
quantiﬁcation in Figure 5D). By contrast, after SNX3 knock-
down to approximately 20% of the control levels (inset in
Figure 4C), approximately 70% of the total HRP-positive
Figure 3. SNX3 Colocalizes with Hrs, Ubiquitinated Proteins, and Clathrin on Rab5
Q79L Enlarged Endosomes.
(A–D) HeLa cells co-expressing both GFP-Rab5
Q79L and mRFP-SNX3 were processed for immunofluorescence using different antibodies as indicated and
analyzed by triple channel fluorescence. Arrowheads point at regions containing GFP-SNX3. Scale bar indicates 10 lm. Insets in the lower right are a
magnification of the regions shown in the boxes.
doi:10.1371/journal.pbio.0060214.g003
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Sorting and Membrane Deformationproﬁles did not seem to contain lumenal vesicles, but were
otherwise similar to controls (Figure 4B, upper panel). All
SNX3 knockdown experiments were repeated with two small
interfering RNA (siRNA) target sequences without signiﬁcant
differences (see Figures 6A, 6B, and S8C).
To better visualize the presence or absence of lumenal
vesicles, ECV/MVBs were labeled with 5-nm proteinA-gold
endocytosed for 30 min at 37 8C with or without nocodazole.
In the mock-treated control, the gold particles distributed
within ECV/MVBs, which typically contained approximately
20 vesicles per proﬁle, whether microtubules were present
(Figure 4A, lower panel) or not (unpublished data). After
SNX3 knockdown, however, 5-nm gold particles labeled
vesicles of the same diameter as ECV/MVBs, but with only
three to ﬁve internal vesicles per proﬁle, whether micro-
tubules were intact (Figure 4B, lower panel) or not
(unpublished data). The appearance and size of internal
vesicles were otherwise undistinguishable from the controls.
Altogether, our data thus indicate that SNX3 plays a direct
and speciﬁc role in the formation of intralumenal membrane
invaginations within nascent ECV/MVBs, since multivesicular
regions are increased by overexpression (Figure 2F) and
decreased by down-expression (Figure 4B).
Interestingly, SNX3 knockdown did not affect virus fusion
(Figure 4C) and caused only a small, marginal decrease in
nucleocapsid release (Figure 4D). Previously, we had found
that the VSV envelope undergoes fusion primarily with the
membrane of ECV/MVB internal vesicles, thus releasing the
capsid into their lumen, where it remains hidden [44]. In late
endosomes, back fusion of these vesicles with the endosome-
limiting membrane then ensures capsid delivery to the
cytoplasm, indicating that VSV fusion and capsid release
occur in sequential steps of the pathway. In particular, we
found that depolymerization of the microtubules, which
reduces early-to-late endosome transport [46], does not affect
viral fusion, but efﬁciently inhibits VSV delivery to late
endosomes and capsid release [44] (see Figure 4D). In contrast
to controls, capsid release was only marginally affected by
microtubule depolymerization in cells treated with SNX3
siRNAs (Figure 4D)—much like in cells treated with PI 3-
kinase inhibitors or Hrs siRNAs [44], which both decrease
intralumenal membranes in endosomes [30,35] (see also
Figure 5B). This was not due to some indirect effects of
SNX3 siRNAs, since early-to-late endosome transport re-
mained microtubule dependent after SNX3 knockdown (see
below and Figure S7A and S7B). It thus appears that, when
ECV/MVBs lack intralumenal vesicles after SNX3 knockdown,
VSV fusion can be triggered at the limiting membrane, thus
by-passing the need for transport to late endosomes—again
much like after PI 3-kinase inhibition or Hrs knockdown [44].
The ‘‘empty’’ endosomes in cells lacking SNX3 closely
resemble endosomes observed after Hrs knockdown in
mammalian cells [30] (see Figure 5B) or mutagenesis in
Drosophila [29]. In these studies, Hrs depletion also inhibited
EGF receptor degradation, supporting the view that sorting
into intralumenal invaginations mediates lysosomal targeting
[13,37]. To our surprise, SNX3 knockdown had little effect on
EGF receptor degradation (Figure S7C), signiﬁcantly less than
Hrs knockdown (see blot in Figure 5A) in parallel experi-
ments (Figure 4E, quantiﬁcation of the blots in Figure 4F).
Consistently, a wave of ﬂuorescent EGF reached late
endocytic compartments containing Lamp1 in cells treated
with SNX3 siRNAs (Figure 4H; quantiﬁcation in Figure 4G) as
in mock-treated cells (Figure S8A), and this transport
required intact microtubules (Figure S7A and S7B). Then,
EGF no longer colocalized with EEA1 in early endosomes
(Figure 4H; quantiﬁcation in Figure 4G) as in mock-treated
cells (Figure S8A). This is in contrast to the inhibition
observed after SNX3 overexpression (Figure 1C–1E). SNX3
knockdown thus appears to prevent the formation of intra-
lumenal invaginations within endosomes without interfering
with EGF receptor transport and degradation, indicating that
the lysosomal targeting of signaling receptors is then
uncoupled from sorting into ECV/MVBs.
Both Hrs and SNX3 seem to play a role in the membrane
invagination process, but only Hrs, and not SNX3, appears to
be involved in EGF receptor targeting to lysosomes, perhaps
suggesting that Hrs acts upstream of SNX3 in receptor
sorting and multivesicular body biogenesis. Consistent with
this notion, Hrs knockdown selectively reduced the expres-
sion of SNX3—without affecting any other protein involved
in endosome membrane dynamics that we tested (Figure
5A)—and in particular decreased the membrane-associated
pool of SNX3 (Figure S8B). By contrast, SNX3 knockdown
had no effect on Hrs expression (Figure 5A and see Figure
S8C). We thus wondered whether the known effect of Hrs
knockdown could be due, at least in part, to reduced levels of
SNX3.
As expected [30], approximately 60% of the total HRP-
labeled endosomes appeared to contain fewer internal
membranes (Figure 5B, left panel; quantiﬁcation in Figure
5D) in cells treated with Hrs siRNAs, much like endosomes in
Figure 4. SNX3 Silencing Inhibits Membrane Formation within MVBs but Does Not Affect EGFR Early-to-Late Endosomal Transport and Degradation
(A) The ECV/MVB content of mock-treated HeLa cells was labeled with endocytosed HRP [22,46]. Samples were processed for plastic embedding after
HRP cytochemical detection, and analyzed by electron microscopy. The micrographs show representative high-magnification views of individual HRP-
containing structures (upper panel). In separate experiments, the ECV/MVB content was labeled with 5-nm proteinA-gold endocytosed for 30 min at 37
8C (lower panel).
(B) As in (A), but cells were treated with SNX3 siRNAs.
(C) SNX3 siRNA or mock-treated HeLa cells were incubated with 3 MOI Dil-labeled VSV and viral fusion was monitored as in Figure 2D (inset: SNX3
down-regulation in cells treated with SNX3 siRNAs).
(D) HeLa cells were treated with SNX3 siRNAs or mock-treated, and then microtubules were depolymerized or not with 10 lM nocodazole. Then, cells
were infected with 0.1 MOI VSV, and RNA replication was quantified as in Figure 2C.
(E and F) HeLa cells treated with SNX3 siRNAs, Hrs siRNAs, or mock-treated were stimulated with EGF and analyzed as in Figure 1A. Blots were scanned
and the quantification is shown in (F).
(G) Individual endosomes containing both EGF and EEA1 or Lamp1 were counted in SNX3 siRNA-treated cells (see [H] below) and in control cells (Figure
S8A). Values are expressed as a percentage of the total number of EGF-containing endosomes in each category (.10 cells per experiment).
(H) EGF-biotin coupled to streptavidin-AlexaFluor 488 was endocytosed as in Figure 1C and 1D in cells treated with SNX3 siRNA. Cells were analyzed by
immunofluorescence with the indicated antibodies. Insets in the lower right are a magnification of the regions shown in the boxes.
In (C and D) and (F and G), each condition is the mean of at least three independent experiments; standard errors are indicated.
(A and B) Scale bar indicates 0.25 lm; (H) scale bar indicates 10 lm.
doi:10.1371/journal.pbio.0060214.g004
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Sorting and Membrane Deformationcells treated with SNX3 siRNAs (Figure 4B)—and in contrast
to endosomes in mock-treated cells (Figure 4A). Parallel
analysis of cells after proteinA-gold internalization revealed
that these endosomes contained ﬁve to ten internal vesicles
per proﬁle, which were otherwise similar to controls (Figure
4A), whether microtubules were intact (Figure 5B, right
panel) or not (unpublished data)—again much like after
SNX3 knockdown and in contrast to controls (Figure 4A and
4B). The multivesicular morphology of endosomes in cells
treated with Hrs siRNAs could, however, be restored by
overexpression of GFP-SNX3 (Figure 5C; quantiﬁcation in
Figure 5D), despite that fact that Hrs expression remained
silenced (Figure S8D). Structures labeled with 5-nm proteinA-
gold then contained approximately 25–30 lumenal vesicles
per proﬁle, similar to endosomes in mock-treated controls.
These data thus strongly suggest that the morphological
phenotype of endosomes in Hrs-depleted cells is at least in
part due to low SNX3 levels, and also demonstrate that SNX3
is a component of the molecular machinery that drives
intralumenal membrane invagination.
It has been suggested that EGF receptor is trafﬁcked
through a subpopulation of multivesicular endosomes in a
process that involves annexin A1 [21]. Annexin A1 is
structurally, functionally, and biochemically related to
annexin A2 [47], and both proteins colocalize on early
endosomes [48,49]. Annexin A2 was also proposed to play a
role in multivesicular endosome biogenesis, but not in the
invagination process [22]. Consistently, endogenous annexin
A1 colocalized with annexin A2-GFP and mRFP-SNX3, and
endogenous annexin A2 with mRFP-SNX3 (Figure S9A).
These observations show that SNX3 is present on endosomes
that contain both annexin A1 and annexin A2.
Next, we investigated whether SNX3 plays a role in the
formation of intralumenal vesicles that mediate EGF receptor
sorting into multivesicular endosomes. To this end, we made
use of the ability of the active Rab5 mutant Rab5Q79L to
form enlarged early endosomes that provide high spatial
resolution by light microscopy [9,50], as in Figure 3. When
mock-treated cells were challenged with EGF for 15 min at 37
8C, the EGF receptor was endocytosed into these enlarged
endosomes, where greater than 50% of the endocytosed
receptor accumulated in the lumen (Figure 6A, quantiﬁcation
in Figure 6B), as expected [50]. Similarly, EGF colocalized
with the receptor in the lumen of these enlarged endosomes
(unpublished data). Knockdown of Hrs with either one of two
siRNAs signiﬁcantly reduced EGF receptor sorting into the
Figure 5. SNX3 Rescues the Formation of Internal Vesicles in Hrs siRNA-Treated Cells
(A) HeLa cells treated with siRNAs against Hrs or SNX3 or mock-treated were lysed. Lysates were analyzed by SDS gel electrophoresis and western
blotting using indicated antibodies. The red box highlights the reduction in SNX3 levels observed after Hrs knockdown.
(B) HeLa cells were treated with Hrs siRNAs. Then, the endosomal content was labeled with HRP (left panel) or 5-nm proteinA-gold (right panel) and
analyzed by electron microscopy as in Figure 4A.
(C) As (B), except that GFP-SNX3 was overexpressed during the last 24 h.
(D) The number of MVBs and ‘‘empty’’ MVBs were counted in the experiments shown in Figure 4A (mock-treated cells), Figure 4B (SNX3 siRNAs), Figure
5B (Hrs siRNAs), and Figure 5C (Hrs siRNAs followed by SNX3 overexpression), and are expressed as a percentage of the total number of HRP-labeled
endosomes (’50 individual endosomes counted for each condition). All structures containing one or more intralumenal vesicles were counted as
MVBs). To ensure unbiased analysis and quantification, micrographs were taken in Brisbane, and each condition was number coded. Analysis and
quantification were then performed blind in Geneva.
doi:10.1371/journal.pbio.0060214.g005
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Figure 6B), consistent with our electron microscopy analysis
(Figure 5B–5D) and in agreement with previous ﬁndings
[30,50]. Similarly, SNX3 depletion with either one of two
siRNAs inhibited EGF receptor incorporation in the lumen of
large endosomes to the same extent as Hrs knockdown
(Figure 6A, quantiﬁcation in Figure 6B). Finally, SNX3 re-
expression in the Hrs knockdown background restored EGF
receptor accumulation in the lumen of enlarged endosomes
to the same extent as observed in mock-treated controls
(Figure 6A, quantiﬁcation in Figure 6B). These observations
unambiguously demonstrate that SNX3 controls the forma-
tion of lumenal membranes that carry the EGF receptor,
further conﬁrming the role of SNX3 in the lumenal
invagination process.
Although reduced levels of SNX3 seemed to account for the
invagination defect in Hrs knockdown cells, SNX3 siRNAs did
not affect EGF receptor transport to late endosomes (Figure
4G–4H) and degradation (Figure 4E and 4F). Similarly, a wave
of endocytosed EGF receptor was exported from EEA1-
positive early endosomes and reached Lamp1-positive late
endosomes (Figure 7A, quantiﬁcation in Figure 7B) under our
conditions of Hrs knockdown (’80%, Figure 5A) much like
in mock-treated cells (Figure S8A) or in cells treated with
SNX3 siRNAs (Figure 4H). Since, under the same Hrs
knockdown conditions, the formation of internal vesicles
(Figures 5B and 6A) and EGF receptor degradation were
inhibited (Figure 4E) and SNX3 levels reduced (Figure 5A),
these observations strongly suggest that Hrs is an essential
component of the lysosome targeting machinery, which can
function independently of receptor sorting into and incor-
poration within multivesicular endosomes.
To further discriminate between Hrs and SNX3 functions,
we made use of anthrax toxin, which is translocated across
the membrane of ECV/MVB intralumenal vesicles. Like VSV
nucleocapsids, the toxin hijacks these vesicles to reach late
endosomes, where back fusion with the limiting membrane
releases the lethal factor into the cytosol, leading to the
cleavage of mitogen-activated protein kinase kinases
(MAPKKs), and in particular MEK1 [51]. After addition of
anthrax toxin, MEK1 cleavage was slightly retarded in cells
treated with Hrs or SNX3 siRNAs (Figure 7C). Presumably, in
the absence of intralumenal membranes (Figures 4B, 5B–5D,
6A, and 6B), toxin translocation could then occur across the
limiting membrane of these ‘‘empty’’ ECV/MVBs—in good
agreement with our observations on VSV capsid release after
Hrs [44] or SNX3 (Figure 4D) knockdown. Interestingly, re-
expression of GFP-SNX3 in the Hrs knockdown background
prevented toxin translocation (Figure 7C). Presumably, the
toxin, once released, remained trapped in the lumen of
intralumenal vesicles. Similarly, EGF receptor degradation
remained inhibited after re-expression of GFP-SNX3 in the
Hrs knockdown background (Figure S9B). Indeed, excess
SNX3 not only restored intralumenal vesicles (Figures 5C, 6A,
and 6B), but also inhibited ECV/MVB detachment (or
maturation), and thus transport beyond early endosomes
towards late endosomes (Figures 1 and 2).
Discussion
It is generally believed that the lysosomal targeting of
signaling receptors is controlled by sorting via Hrs and its
downstream ESCRT partners into membrane invaginations
on early endosomal regions, which will become multivesicular
endosomes. Then, intralumenal vesicles are transported to
lysosomes, where they are degraded together with their
receptor cargo. Our observations now demonstrate that
lysosomal targeting can function independently of this
multivesicular endosome sorting event, since the transport
of EGF receptor to late endocytic compartments and its
degradation are not affected by SNX3 knockdown, in the
absence of ECV/MVB lumenal membranes (see model in
Figure S10). This agrees with previous observations that PI 3-
Figure 6. SNX3 Controls the Formation of Intralumenal Vesicles That
Incorporate the EGF Receptor
(A and B) HeLa cells were mock-treated or treated with siRNAs against
SNX3 or Hrs (two different siRNAs in each case) and transfected with
GFP-Rab5
Q79L (green) during the last 24 h. Alternatively, mRFP-SNX3 was
overexpressed in cells treated with each anti-Hrs siRNA. After cell surface
binding, EGF was internalized for 15 min at 37 8C. Cells were labeled with
anti-EGF-R antibodies (blue) and analyzed by confocal microscopy. In (B),
the relative amount of EGF-R in the lumen of endosome was quantified
[50] and expressed as the percentage of the total amount of EGF-R. Each
condition is the mean of at least three independent experiments;
standard errors are indicated. (A) Scale bar indicates 10 lm. Insets in the
lower left are a magnification of the regions shown in the boxes.
doi:10.1371/journal.pbio.0060214.g006
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lumenal vesicles, but not the delivery of the EGF receptor to
the lysosomes [35]. A corollary of these observations, however,
is that Hrs indeed controls lysosome targeting, as expected
[29,30,52], but that this function can be uncoupled from the
invagination process in the multivesicular pathway towards
late endosomes. Even in the absence of ECV/MVB lumenal
membranes after SNX3 knockdown, sorting into putative Hrs
platforms [53] is sufﬁcient to ensure, not only receptor
transport to late endosomes, but also packaging into
lysosomes and degradation.
Whereas Hrs is necessary for lysosomal targeting, the
protein appears to be dispensable for the membrane
invagination process that leads to ECV/MVB biogenesis. By
contrast, SNX3, which is dispensable for lysosomal targeting,
appears to function as a necessary component of the
molecular machinery that drives the formation of membrane
invaginations within forming ECV/MVBs. Indeed, SNX3
knockdown inhibits the invagination process, whereas excess
SNX3 promotes the formation of intralumenal membranes
and the accumulation of multivesicular regions on early
endosomes. It thus appears that PtdIns3P signaling regulates
differentially lysosomal targeting and the biogenesis of ECV/
MVBs, via at least two PtdIns3P effectors, Hrs and SNX3,
which act sequentially in the pathway. Although our data
demonstrate that SNX3 regulates the membrane invagination
process itself, the molecular mechanism is unclear. In yeast,
the SNX3 homolog Grd19p is involved in selective retrieval of
some membrane proteins from the prevacuolar compart-
ment, presumably late endosomes, to the TGN [54,55]. It is
not known whether the function of yeast Grd19p is somehow
related to the function we propose for SNX3 in mammalian
Figure 7. MEK1 Cleavage by Anthrax Toxin Lethal Factor
(A and B) Experiments (A) and quantification (B) were as in Figure 4G and 4H, except that cells were treated with Hrs siRNAs. Insets in the lower right are
a magnification of the regions shown in the boxes.
(C) Hrs or SNX3 was knocked down, or Hrs was knocked down and GFP-SNX3 overexpressed. The trypsin-nicked Protective Antigen (500 ng/ml) and the
Lethal Factor (100 ng/ml) of anthrax toxin were then bound to the cell surface on ice [51], and cells were incubated at 37 8C. Lysates (40 lg) were
analyzed by western blotting using antibodies against MEK1 N-terminus to detect MEK1 cleavage by Lethal Factor released into the cytosol.
In (B), each condition is the mean of at least three independent experiments; standard errors are indicated. (A) Scale bar indicates 10 lm.
doi:10.1371/journal.pbio.0060214.g007
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different roles, since endosome-to-Golgi transport of Shiga
toxin B-subunit seems to require not SNX3 (this study), but
SNX1 [43].
Several proteins and lipids were reported to play a role in
the formation of intralumenal membranes, including Hrs and
ESCRTs [13,14], SNX3 (this study), ceramide [50], and
perhaps, LBPA and Alix [56]. Future work will be needed to
determine the precise relationships that may exist between
these components. At present, our observations indicate that
SNX3 functions downstream of Hrs, and one may speculate
that it recruits other proteins, perhaps ESCRTs, which then
drive the invagination process. However, SNX3 is a short
member of this protein family that does not contain any
structural feature other than the PX domain itself [38,40].
Moreover, we failed to detect ESCRT components in SNX3
pull-downs, and two-hybrid screens showed that Grd19p
interacts with proteins of the early secretory pathway, but the
signiﬁcance of these observations is not clear [57]. Alter-
natively, SNX3 itself may play a direct role in the invagination
process by deforming membranes in a direction opposite to
BAR-containing proteins [39].
Materials and Methods
Cells, antibodies, reagents, and constructs. Cell maintenance was
described [46], as was the mouse monoclonal anti-LBPA antibody
[58]. We are very grateful to Ludger Johannes (Paris. France) for
supplying us with Cy3-labeled Shiga toxin B-subunit; to Reinhard
Jahn (Go ¨ttingen. Germany) and Volker Gerke (Muenster. Germany)
for mouse monoclonal antibodies against RAB5 and annexin A2
(HH7), respectively; to Wanjin Hong (Singapore. Singapore), Harald
Stenmark (Oslo, Norway), and Marino Zerial (Dresden, Germany) for
rabbit polyclonal antibodies against SNX3 or SNX16, Hrs, and EEA1,
respectively. We also used mouse monoclonal antibodies against: GFP
(Roche Diagnostics); transferrin receptor (Zymed Laboratories);
EEA1 and annexin A1 (Transduction Laboratories); human LAMP1
(Pharmacia); EGF receptor (BD Biosciences); a-tubulin (Sigma-
Aldrich); ubiquitinated proteins (FK2) (Afﬁnity Research Products);
clathrin (X22) (ABR-Afﬁnity BioReagents); and TSG101 (GeneTex).
Polyclonal antibodies made in rabbit against Rab6 were from Santa
Cruz Biotechnology and made in sheep against the EGF receptor
from Fitzergald. HRP-labeled secondary antibodies were from
Amersham or Sigma-Aldrich and ﬂuorescently labeled secondary
antibodies from Jackson Immunoresearch Laboratories. Wortman-
nin, nocodazole, EGF, HRP, and o-dianisidine were from Sigma-
Aldrich, EGF-biotin, streptavidin R-phycoerythrin conjugate, Alexa-
Fluor 488 EGF complex, 10-kDa rhodamine dextran from Molecular
Probes. ProteinA-gold (5 nm) was from Utrecht University. We
obtained pGFP-Rab5
Q79L from Marino Zerial (Dresden. Germany),
GFP-tagged SNX1 and Flag-tagged SNX2 from Gordon N. Gill
(University of California, San Diego, California), myc-tagged SNX3
from Carol R. Haft (National Institutes of Health, Bethesda, Mary-
land), and pDMYC-SNX16 from Wanjin Hong (Singapore, Singa-
pore). SNX1, SNX2, and SNX3 were ampliﬁed by PCR and introduced
into pEGFP-C2 or fused with mRFP.
Viral fusion, RNA replication, and infection. In experiments using
VSV, the fusion of the viral envelope with endosomal membranes, the
replication of viral RNA, and the appearance of the viral glycoprotein
G in the host-cell biosynthetic pathway were analyzed as described
[44]. Brieﬂy, VSV fusion was measured using virus labeled with self-
quenching amounts of the ﬂuorescent dye Dil (long-chain dialkylcar-
bocyanine). Labeled virions were bound to the plasma membrane on
ice and then cells were incubated for 35 min at 37 8C. Individual VSV
fusion events resulted in the appearance of brightly ﬂuorescent spots
upon dye dequenching. For quantiﬁcation, cells containing fused
virions were counted. The replication of VSV RNA minus-strand was
quantiﬁed by TaqMan RT-PCR; total RNA was extracted from
infected HeLa cells, precipitated, and used for retrotranscription
using speciﬁc oligonucleotides of the genomic VSV-G RNA. Finally,
G-protein appearance in biosynthetic membranes 3 h postinfection
was visualized by immunoﬂuorescence using anti-VSV-G antibodies.
Endocytic transport in vivo. Cells were transfected with FuGene
(Roche Diagnostics) according to the manufacturer’s instructions. In
RNA interference (RNAi) experiments, cells were transfected twice at
a 24-h interval using OligoFectamin (Invitrogen) with 21-nucleotide
RNA duplexes (Qiagen), replated 4 h after the second transfection,
and analyzed 36 h later. In HeLa cells, we used an Hrs target sequence
siRNA1 that was described [30] and already used in our previous
studies [44], as well the target sequence siRNA2 59-AAGCGGAGG-
GAAAGGCCACTT-39; the target SNX3 sequences were: siRNA1, 59-
AAGGGCTGGAGCAGTTTATAA-39; siRNA2, 59-AACAAGGGCTG-
GAGCAGTTTA-39. To follow ﬂuid phase transport, cells were
incubated for 10 min at 37 8C with 2.5 mg/ml rhodamine-dextran
(pulse) and further incubated for 40 min without the marker (chase)
when indicated. Alternatively, cells were incubated for 1 h at 4 8C
with 1 lM Cy3-labeled Shiga toxin B-subunit, or incubated for 1 h at 4
8C with 400 ng/ml EGF-biotin-streptavidin-R-phycoerythrin complex
or 500 ng/ml EGF-biotin-streptavidin-AlexaFluor488 complex. Then,
the marker was endocytosed for the indicated time periods at 37 8C.
To quantify EGF receptor degradation, cells were preincubated in
serum-free medium, and incubated with 0.25 lg/ml EGF and 10 lg/ml
cycloheximide for the indicated time periods. Microtubules were
depolymerized with 10 lM nocodazole for 2 h [46,59]. When
indicated, cells were incubated for 1 h at 4 8C with 500 ng/ml
trypsin-nicked Protective Antigen (PA) and 100 ng/ml Lethal Factor
(LF) of anthrax toxin, and then transferred to 37 8C for different
periods of time in a toxin-free medium, as described [51].
Microscopy. Immunoﬂuorescence microscopy has been described
[60]. For annexin immunolabeling, cells were permeabilized before
ﬁxation with 100 mM KCl, 2 mM MgCl2, 1 mM CaCl2, and 1 mM
Hepes (pH 6.9) containing 0.1% triton X-100 [61]. In some experi-
ments, 500 ng/ml EGF-biotin-streptavidin-AlexaFluor488 complex
was bound for 1 h at 4 8C to the surface of cells overexpressing
Rab5Q79L, and then the complex was endocytosed for 15 min at 37
8C. The quantiﬁcation of EGF receptor distribution in the lumen or
on the limiting membrane of enlarged endosomes has been described
[50]. Pictures were captured using a Zeiss Axiophot microscope
equipped with a 633 Plan-NOEFLUAR objective or a Zeiss LSM 510
META confocal microscope equipped with a 633 Plan-Apochromat
objective. To visualize the content of ECV/MVBs by electron
microscopy, HRP was endocytosed for 15 min at 37 8C followed by
a 30-min chase after microtubule depolymerization [22,46]. Cells were
then ﬁxed, HRP was revealed cytochemically with DAB as substrate,
and processed for plastic embedding [62]. Alternatively, cells were
incubated with 5-nm proteinA-gold (optical density [OD] at 520 nm¼
10) for 30 min with or without microtubule depolymerization to label
ECV/MVBs, and samples were processed as above. In this analysis, it
was not possible to identify unambiguously cells that have been
transfected. However, given the extent of knockdown observed on
western blots (80%–90%), the corresponding protein (Hrs or SNX3)
must be depleted in at least four out of ﬁve (or nine out of ten) cells, if
depletion were complete in most cells, rather than partial in all cells.
The latter view is consistent with observations that 100% of the cells
were labeled with ﬂuorescently labeled siRNAs (unpublished data). In
any case, to ensure unbiased electron microscopy analysis and
quantiﬁcation of both HRP and proteinA-gold experiments, samples
were prepared in Geneva and analyzed by western blotting to ensure
that knockdown and re-expression of SNX3 were efﬁcient. Then,
samples were shipped to Brisbane. There, each experiment was
number coded and analyzed by electron microscopy. The corre-
sponding micrographs in number-coded folders were then trans-
ferred to Geneva. Analysis and quantiﬁcation were then performed
blind in Geneva. Electron microscopy after immunogold labeling of
cryosections has been described [63].
Other methods. LBPA quantiﬁcation by ELISA [58] was described,
as was early and late endosome fractionation by ﬂotation in a sucrose
step gradient [59].
Supporting Information
Figure S1. GFP-SNX3 Is Present on Early Endosomes and This
Distribution Depends on PtdInsI3P
(A) HeLa cells expressing GFP-SNX3 were processed for immuno-
ﬂuorescence using the indicated antibodies.
(B) BHK cells expressing GFP-SNX3 were homogenized and a
postnuclear supernatant (PNS) was prepared. From this PNS, early
endosomes (EE) were separated from late endosomes (LE) and heavy
membranes (HM) by ﬂoatation in a sucrose step gradient [59,64].
Fractions were analyzed by SDS gel electrophoresis and western
blotting, using antibodies against GFP to detect GFP-SNX3 or against
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antibodies against the late endosomal marker LBPA (lower panel).
(C) HeLa cells expressing GFP-SNX3 or the 3-phosphoinositide-
binding defective mutant GFP-SNX3
R70A were treated or not with 100
nM wortmannin for 30 min at 37 8C and then analyzed by
ﬂuorescence microscopy. SNX3
R70A was no longer membrane-
associated, much like the SNX3 R69RY to AAA triple mutant and
Y71A single mutant [40].
(A and C) Scale bar indicates 10 lm.
Found at doi:10.1371/journal.pbio.0060214.sg001 (516 KB PDF).
Figure S2. The Internalization of EGFR, Dextran, and Shiga Toxin B-
Subunit Is Not Affected in Cells Expressing GFP-SNX3
(A) HeLa cells expressing GFP-SNX3 were incubated with biotin-EGF
coupled with streptavidin-R-phycoerythrin for 1 h at 4 8C, chased for
10 min at 37 8C, and analyzed by ﬂuorescence microscopy after
labeling with antibodies against EEA1.
(B) HeLa cells expressing GFP-SNX3 were incubated with rhodamine-
dextran for 10 min at 37 8C, and analyzed as in (A).
(C) HeLa cells expressing GFP-SNX3 were incubated with 1 lM Shiga
toxin B-subunit conjugated to Cy3 for 1 h at 4 8C, chased for 10 min
at 37 8C, and analyzed by ﬂuorescence microscopy after labeling with
antibodies against the transferrin receptor.
(A–C) Scale bar indicates 10 lm.
Found at doi:10.1371/journal.pbio.0060214.sg002 (703 KB PDF).
Figure S3. SNX3 in Endosomal Transport
(A) After cell surface binding, biotin-EGF coupled to streptavidin-R-
phycoerythrin was internalized for 50 min at 37 8C in HeLa cells
expressing GFP-SNX3. Cells were labeled with antibodies against
Lamp1 and analyzed by triple channel ﬂuorescence; the various
combinations of merged colors are shown for the micrographs in
Figure 1C.
(B) The experiment was as in (A), but cells were labeled with
antibodies against EEA1. The various combinations of merged colors
are shown for the micrographs in Figure 1D.
(C) Rhodamine-dextran was pulsed for 10 min at 37 8C in HeLa cells
expressing GFP-SNX3 and then chased for 40 min. Cells were labeled
with antibodies against Lamp1. The various combinations of merged
colors are shown for the micrographs in Figure 1F.
(D) After cell surface binding, Shiga toxin B-subunit conjugated to
Cy3 was internalized for 50 min at 37 8C into HeLa cells expressing
GFP-SNX3, and cells were analyzed using antibodies against Rab6.
The various combinations of merged colors are shown for the
micrographs in Figure 1G.
(A–D) Scale bar indicates 10 lm
Found at doi:10.1371/journal.pbio.0060214.sg003 (1.76 MB PDF).
Figure S4. EGFR, Dextran, and Shiga Toxin B-Subunit Transport in
Control Cells
(A) HeLa cells were incubated with biotin-EGF coupled with
streptavidin-R-phycoerythrin for 1 h at 4 8C and then chased for 50
min at 37 8C. Cells were then labeled with antibodies against EEA1
and analyzed by ﬂuorescence microscopy.
(B) HeLa cells were incubated with rhodamine-dextran for 10 min at
37 8C, chased for 40 min, and then analyzed by ﬂuorescence
microscopy after labeling with antibodies against Lamp1.
(C) HeLa cells were incubated with 1 lM Shiga toxin B-subunit
conjugated to Cy3 for 1 h at 4 8C and then chased for 50 min at 37 8C.
Cells were then labeled with antibodies against Rab6 and analyzed by
ﬂuorescence microscopy.
(A–C) Scale bar indicates 10 lm.
Found at doi:10.1371/journal.pbio.0060214.sg004 (722 KB PDF).
Figure S5. Overexpression of SNX1, SNX2, or SNX16 Does Not Affect
Transport of the EGF Receptor to Late Endosomes and Lysosomes
HeLa cells expressing GFP-SNX1 (A), GFP-SNX2 (B), or myc-SNX16
(C) were incubated with biotin-EGF coupled with streptavidin-R-
phycoerythrin for 1 h at 4 8C and then chased for 50 min at 37 8C.
Cells were then labeled with antibodies against Lamp1 (A–C) or myc
(C) and analyzed by ﬂuorescence microscopy.
(A–C) Scale bar indicates 10 lm.
Found at doi:10.1371/journal.pbio.0060214.sg005 (535 KB PDF).
Figure S6. GFP-SNX3 Expression Causes an Expansion of the
Multivesicular Regions of Early Endosomes
Control HeLa cells (A) or HeLa cells expressing GFP-SNX3 (B) were
ﬁxed, embedded in Epon, and then processed for electron micro-
scopy. Arrows point at structures with a characteristic multivesicular
appearance. In (B), arrowheads surround a group of seven or eight
multivesicular structures—such clusters were frequently observed in
cells overexpressing GFP-SNX3 (quantiﬁcation is shown in Figure 2E).
Scale bar indicates 1 lm.
Found at doi:10.1371/journal.pbio.0060214.sg006 (403 KB PDF).
Figure S7. Early-to-Late Endosomal Transport Is Not Affected in
Cells Treated with SNX3 siRNAs, and Depends on an Intact
Microtubule Network
(A and B) HeLa cells were treated with SNX3 siRNAs, and then
microtubules were depolymerized (B) or not (A) with 10 lM
nocodazole for 2 h. EGF-biotin coupled to streptavidin-AlexaFluor
488 was endocytosed for 50 min at 37 8C, and cells were analyzed by
immunoﬂuorescence using antibodies against Lamp1. Scale bar
indicates 10 lm.
(C) HeLa cells expressing GFP-SNX3 were incubated with 0.25 lg/ml
EGF and 10 lg/ml cycloheximide for the indicated time periods, as in
Figures 1A and 4E. Cell lysates (100 lg) were analyzed by SDS gel
electrophoresis and western blotting with an antibody raised against
the puriﬁed recombinant partial cytoplasmic domain of human
EGFR, as in Figures 1A and 4E. A blot of the complete gel is shown to
illustrate the fact that degradation intermediates were not detected
with this antibody. The arrow points at a nonspeciﬁc band.
Found at doi:10.1371/journal.pbio.0060214.sg007 (555 KB PDF).
Figure S8. Treatment with siRNAs
(A) HeLa cells treated with mock siRNAs were incubated with 500 ng/
ml EGF-biotin coupled with streptavidin-AlexaFluor 488 for 1 h at 4
8C, chased for 50 min at 37 8C, and analyzed by ﬂuorescence
microscopy after labeling with antibodies against EEA1 or Lamp1, as
indicated. The quantiﬁcation of these experiments is shown in Figure
4G. Scale bar indicates 10 lm.
(B) HeLa cells were mock-treated or treated with siRNAs against Hrs
or SNX3 for 72 h. After homogenization, postnuclear supernatants
were prepared and fractionated by high-speed centrifugation.
Membranes and cytosol were recovered from the high-speed pellet
(HSP) and high-speed supernatant (HSS), respectively, and analyzed
by SDS gel electrophoresis and western blotting using the indicated
antibodies.
C) HeLa cells were mock-treated or treated with two different siRNAs
against SNX3 (1 and 2) or against Hrs (Hrs2) for 72 h. Cells were
harvested and total lysates were analyzed by SDS gel electrophoresis
and western blotting using antibodies against Hrs, SNX3, and actin.
(D) HeLa cells were mock-treated or treated with siRNAs against Hrs
for 72 h. GFP-SNX3 was overexpressed during the last 24 h of the Hrs
RNAi treatment. Cells were then harvested and total lysates were
analyzed by SDS gel electrophoresis and western blotting using
antibodies against a-tubulin, Hrs, and SNX3.
Found at doi:10.1371/journal.pbio.0060214.sg008 (557 KB PDF).
Figure S9. GFP-SNX3 Is Present on Early Endosomes Containing
Both Annexin A1 and Annexin A2
(A) HeLa cells expressing mRFP-SNX3 and/or GFP-Anx A2 were ﬁxed
[61] and processed for immunoﬂuorescence using the indicated
antibodies. Scale bar indicates 10 lm.
(B) HeLa cells were mock-treated or treated with siRNAs against Hrs
with or without GFP-SNX3 overexpression (as in Figures 5C and 6),
and then incubated with 0.25 lg/ml EGF and 10 lg/ml cycloheximide
for the indicated time periods. Cell lysates (100 lg) were analyzed by
SDS gel electrophoresis and western blotting with antibodies against
EGFR (as in Figures 1A and S7C) or actin.
Found at doi:10.1371/journal.pbio.0060214.sg009 (1.10 MB PDF).
Figure S10. Model
The current view is that, after endocytosis, the ubiquitinated EGF
receptor (EGF-R) is sorted into membrane regions of the early
endosome that are coated with clathrin and enriched in PtdInsI3P
(sorting platforms). Then, EGF-R interacts sequentially with ESCRT I,
II, and III complexes and is incorporated into membrane invagina-
tions (in green), giving rise to a forming ECV/MVB [14,37]. The
lumenal vesicles are transported to late endosomes and eventually to
lysosomes, where they are degraded together with their receptor
cargo. Our previous studies show that VSV envelope fuses with ECV/
MVB lumenal membranes, thereby delivering the viral capsid to the
lumen of these internal vesicles, where it remains hidden [44]. After
delivery to late endosomes, back fusion with the limiting membrane
ensures capsid delivery to the cytoplasm. The delivery of anthrax
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Sorting and Membrane Deformationtoxin lethal factor to the cytoplasm [51] follows a pathway very similar
to that of the nucleocapsid (not indicated here for the sake of
simplicity).
(A) SNX3 Overexpression. Our observations indicate that SNX3
overexpression causes an accumulation of multivesicular regions on
early endosomes and inhibits ECV/MVB detachment from early
endosomes (or maturation) and thus interferes with more-distal
transport steps. Then, VSV and EGF-R remain in early endosomes
and viral RNA release is inhibited. By contrast, Hrs overexpression
was reported to mimic its down-expression by RNAi [11,65].
(B) SNX3 RNAi. We ﬁnd that SNX3 knockdown reduces the
formation of ECV/MVB lumenal vesicles, but not EGF-R transport
to late endosomes and degradation in lysosomes, indicating that EGF-
R sorting can be uncoupled from its incorporation into ECV/MVB
lumenal vesicles. Presumably, Hrs (which is not affected by SNX3
knockdown) then ensures proper EGFR targeting to the lysosomes.
Consistently, the delivery of viral RNA to the cytoplasm after SNX3
knockdown no longer requires transport to late endosomes,
presumably because virions then fuse with the limiting membrane
of ‘‘empty’’ ECV/MVBs, devoid of internal vesicles.
(C) Hrs RNAi. Hrs knockdown reduces the formation of ECV/MVB
lumenal vesicles [20,29,30] and causes a concomitant decrease in
SNX3, which is likely to be responsible for the reduction in lumenal
vesicles. Indeed, these can be restored by SNX3 re-expression after
Hrs knockdown. After Hrs knockdown, the delivery of viral RNA to
the cytoplasm no longer requires transport to late endosomes,
because virions then fuse with the limiting membrane of ‘‘empty’’
ECV/MVBs [44]—much like after SNX3 knockdown. In addition, EGF-
R transport to late endosomes is not affected, again much like after
SNX3 knockdown. These data together with observations from others
that EGF-R can be transported towards lysosomes after Hrs knock-
down [20] suggest that Hrs functions are dispensable for early-to-late
endosomal transport. Then, EGF-R sorting in early endosomes may
be achieved by other components of the sorting machinery.
Alternatively, a disruption of this machinery may allow uncontrolled
EGF-R incorporation into the degradation pathway, including, for
example, nonubiquitinated molecules. In any case, and in marked
contrast to SNX3 knockdown, we ﬁnd that EGF-R degradation in
lysosomes is seriously compromised by Hrs knockdown, as observed
by others [29,30], conﬁrming the crucial function of Hrs for EGF-R
lysosomal targeting.
Found at doi:10.1371/journal.pbio.0060214.sg010 (46 KB PDF).
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